Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001191434-18-000002

Options or other derivatives

  • Exec. Vice Chairman/CEO/Pres. acquired 371,622 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Equels Thomas K. Exec. Vice Chairman/CEO/Pres. 2018-02-13 Grant or award · Options to buy Common Stock +371,622 371,622 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…